1 |
Johnson TL, Lloyd RV,Thompson NW, Beierwaltes WH, Sisson JC : Prognostic implications of the tall cell variant ofpapillary thyroid carcinoma. Am J Surg Pathol. 1988 ; 12 : 22-27
DOI
PUBMED
ScienceOn
|
2 |
Terry JH, St. John SA, Karkowski FJ, et al : Tall cell papillary thyroid cancer: incidence and prognosis. Am J Surg. 1994 ; 168 : 459-461
DOI
ScienceOn
|
3 |
Ruter A, Dreifus J, Jones M, Nishiyama R, Lennquist S : Overexpression of p53 in tall cell variants of papillary thy-roid carcinomo. Surgery. 1996 ; 120 : 1046-1050
DOI
PUBMED
ScienceOn
|
4 |
Guidi AJ, Abu-Jawdeh G, Berse B : 'Vascular permeability factor (Vascular endothelial growth factor. expression and angiogenesis in cervical neoplasia.' J Natl Cancer Inst. 1995 ; 87 : 1237-1245
|
5 |
Fellmer PT, Sato K, Tanaka R, et al : vaseular endothelial growth faetor-c gene expression in papillary and follicular thyroid cancinomas. Surgery. 1999 ;126 (6) : 1056-1061
DOI
ScienceOn
|
6 |
Fenton C, Patel A, Dinauer C, Robie DK, Tuttle RM, Francis GL : The expression of vascular endothelial growth factor and the type 1 vascular endothelial growth factor receptor correlate With the size of papillary thyroid carcinoma in children and young adults. Thyroid. 2000 ; 10 (4) : 349-357
DOI
ScienceOn
|
7 |
Scheumman GF, Hoang-Vue, Cetin Y, Gimm 0, Behrends J, Von Wasielewski R, Georgii S, Birchmeier W, Von Zurmuhlen A, Dralle H : Clinical Significance of Escadherin as a prognostic marker in throid carcinomas. J Clin Endocrinol Metal. 1995 ; 80 (7) : 2168-2172
DOI
ScienceOn
|
8 |
Hedinger C : Histologic typing of thyroid tumors. In : International histological classification of tumours. vol 11. Geneva: World Heath Organization, 1974
|
9 |
Flint A, Davenport RD, Lloyd RV : The tall cell variant ofpapillary carcinoma ofthe thyroid. Comparison with the com-mon form of papillary carcinoma by DNA and morpho-metric analysis. Arch Pathol Lab Med. 1991 ; 115 : 169-171
|
10 |
Naito A, IwaseH, Kuzushima T, Nakamura T, Kobayashis : Clinical significance of E-cadherin expressin in thyroid neoplasm. ; Surg Oncol. 2001 ; 76 (3) : 176-180
|
11 |
Kinsella AR, Green B, Lepts GC, Hill CS, Bowie G, Taylor, BA : 'The role of the cell-cell adhesion molecule E-cadherin in large bowel tomour cell invasion and metastasis.' Br J Cancer. 1993 ; 67 : 904-909
DOI
PUBMED
ScienceOn
|
12 |
Ito T, Seyama T, Mizuno T, et al : Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas ofthe thyroid gland. Cancer Res. 1992 ; 52 : 1369-1371
PUBMED
|
13 |
Pignattelli M, Ansari TW, Gunter P : 'Loss of membranous Ecadherin expression in pancreatic cancer. correlation with lymph node metastasis, high grade, and advanced stage.' J Pathol. 1994 ; 174 : 243-248
|
14 |
Raycroft L, Wu H, Lozano G : Transcriptional activa-tion by wild-type but not transforming mutants ofthe p53 anti-oncogene. Science. 1990 ; 249 : 1049-51
DOI
PUBMED
|
15 |
Shimovama Y, Hirohash S, Hirano S : 'Cadherin cell adhesion molecules in human epithelial tissue and carcinomas.' Cancer Res. 1989 ; 49 : 2128-2133
|
16 |
Shiozaki H, Tahara H, Oka H : 'Expression of immunoreactive E-cadherin adhesion molecules in human cancers.' Am J Pathol. 1991 ; 139 : 27-23
|
17 |
van den Brekel MWM, Hekkenberg RJ, Asa SL, Tomlinson G, Rosen IB, Freenal JL : Prognostic features in tall cell papillary carcinoma and insular thyroid carcinoma. Laryngo-Scope. 1997 ; 107 : 254-259.
DOI
ScienceOn
|
18 |
Klein M, Vignaud 1M, Hennoguin V, et al : Increased expression of the vascular endothelial growth factor is a prejorative prognosis marker in papillary thyroid carcinoma. J Clin Endocrinol Metab. 2001 ; 86 (2) : 656-658
DOI
ScienceOn
|
19 |
Soares P, Berex G, Van Roy F, Sobrinho-Simoes M : E-cadherin gene alterations are rare events in thyroid tumors. Int S cancer. 1997 ; 6 ; 70 (I) : 32-38
|
20 |
Walgenbach S, Sternheim E, Bittinger F, Gorges R, Andreas J, Junginger T : Prognostic value of E-cadherin in papillary thyroid carcinoma. Chirurg. 1998 ; 69 (2) : 186-190
DOI
ScienceOn
|
21 |
Ostrowski ML, Merino MJ : Tell cell variant ofpapillary thyroid carcinoma. Am J Surg Pathol. 1996 ; 20 : 964-974
DOI
ScienceOn
|
22 |
Dobashi Y, Sakamoto A, Sugimora H, et al : Overexpression of p53 as a possible prognostic factor in human thyroid car-cinoma. Am J Surg Pathol. 1993 ; 17 : 375-381
DOI
ScienceOn
|
23 |
De Vries C, Escobedo JA., Veno H, Houck K, Ferrara N, Williams LT : 'The fms-like tyrosine kinase, a receptor for vascular endothelial growthfactor.' Science. 1992 ; 255 : 989-991
DOI
PUBMED
|